- Latest week
- 10 Jul 2026
- Close
- 272.399994
- Fair value
- 196.491395
- Next-week expectancy
- Undecided 51.46%
MARKSANS Chart Pack
Marksans Pharma Limited
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, MARKSANS rose 43.21%, moving from 190.21 to 272.40. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 43.89 and has improved across the 12-week window. Market Dynamics is 1.71 on the latest week. Next-week expectancy is undecided at 51.46% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 272.40
- 12-Week Change
- 43.21%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 51.46%
- Signal Weeks
- 8 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 43.89
- Market Dynamics
- 1.71
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 272.40
- 12-Week Change
- 43.21%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 51.46%
- Signal Weeks
- 8 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 43.89
- Market Dynamics
- 1.71
Over the latest 12 completed weeks ending 2026-07-10, MARKSANS rose 43.21%, moving from 190.21 to 272.40. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 43.89 and has improved across the 12-week window. Market Dynamics is 1.71 on the latest week. Next-week expectancy is undecided at 51.46% based on similar historical setup states.
Industry Peers
India equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| RUBICON RUBICON RESEARCH LIMITED | NSI | 10 Jul 2026 | 1330.50 | 1439.00 | 1320.00 | 1431.40 | 7.58% |
| PFIZER Pfizer Limited | NSI | 10 Jul 2026 | 4570.00 | 4747.80 | 4503.40 | 4731.40 | 3.53% |
| GLAXO GlaxoSmithKline Pharmaceuticals Limited | NSI | 10 Jul 2026 | 2390.20 | 2460.80 | 2370.00 | 2438.20 | 2.01% |
| SENORES SENORES PHARMACEUTICALS L | NSI | 10 Jul 2026 | 1389.90 | 1487.90 | 1313.60 | 1417.80 | 2.01% |
| KOPRAN Kopran Limited | NSI | 10 Jul 2026 | 195.99 | 198.00 | 179.93 | 196.82 | 0.42% |
| TTKHLTCARE TTK Healthcare Limited | NSI | 10 Jul 2026 | 923.10 | 942.45 | 880.60 | 920.40 | -0.29% |
| SANOFI Sanofi India Limited | NSI | 10 Jul 2026 | 3425.00 | 3488.90 | 3340.00 | 3401.90 | -0.67% |
| SANOFICONR SANOFI CONS HEALTHC IND L | NSI | 10 Jul 2026 | 4602.90 | 4726.00 | 4500.30 | 4566.70 | -0.79% |
| NGLFINE NGL Fine-Chem Limited | NSI | 10 Jul 2026 | 3230.00 | 3329.00 | 3027.10 | 3193.60 | -1.13% |
| SMSPHARMA SMS Pharmaceuticals Limited | NSI | 10 Jul 2026 | 423.30 | 435.00 | 398.25 | 402.70 | -4.87% |